Recruiting Clinical Trials

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

By April 24, 2017 No Comments


Malignant Mesothelioma|Pancreatic Cancer|Ovarian Tumor|Triple Negative Breast Cancer|Endometrial Cancer|Other Mesothelin Positive Tumors

Estimated Enrollment: 20

Age Group: 18 Years to 70 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: s2015-080-06

Study First Received: October 19, 2015

Last Updated: October 19, 2015

Estimated Primary Completion Date: November 2017


Primary Outcome Measures:

Occurrence of Study related adverse events|Anti-tumor responses to CART-meso cell infusions

Sponsors and Collaborators:

Chinese PLA General Hospital

Website Link:

Leave a Reply

Call Now ButtonCall Now